. The requirement for sustained and efficient vaccination against leishmaniasis is to formulate the best combination of immunopotentiating adjuvant with the stable antigen (Ag) delivery system. The aim of the present study is to evaluate the effectiveness of an immunomodulator on liposomal Ag through subcutaneous (s.c.) route of immunization, and its usefulness during prime/boost against visceral leishmaniasis (VL) in BALB/c mice.) challenge. Moreover, combined formulations offered superior protection against intracellular amastigote replication in macrophages in vitro, and hepatic and splenic parasite load in vivo.Our results define the immunopotentiating effect of MPL-TDM on protein Ag encapsulated in a controlled release system against e...
Background: With the paucity of new drugs and HIV co-infection, vaccination remains an unmet researc...
The difficulty in making successful vaccines against leishmaniasis is partly due to lack of an appro...
The difficulty in making successful vaccines against leishmaniasis is partly due to lack of an appro...
. The requirement for sustained and efficient vaccination against leishmaniasis is to formulate the ...
Numerous experimental DNA vaccines have been tested against Leishmania, whose clinical use is mostly...
AbstractObjectiveTo analyze the protective efficacy of recombinant 78 kDa antigen of Leishmania dono...
In this study, we have developed a vaccine with Leishmania donovani promastigote membrane antigens (...
Visceral leishmaniasis is deadly if not treated, and development of a vaccine with long-term immunit...
Liposomes have been widely exploited as antigen delivery systems for a variety of diseases including...
Leishmanial antigens (LAg) were used as a vaccine against Leishmania donovani, the causative agent o...
<div><p>Background</p><p>With the paucity of new drugs and HIV co-infection, vaccination remains an ...
Leishmania proteins have been evaluated as vaccine candidates against leishmaniasis; however, most a...
Background: The observation that recovery from infection with Leishmania confers immunity to reinfec...
Leishmaniasis affects 12 million people, and it is generally agreed that vaccination provides the be...
In the search for a leishmaniasis vaccine, extensive studies of cutaneous leishmaniasis have been ca...
Background: With the paucity of new drugs and HIV co-infection, vaccination remains an unmet researc...
The difficulty in making successful vaccines against leishmaniasis is partly due to lack of an appro...
The difficulty in making successful vaccines against leishmaniasis is partly due to lack of an appro...
. The requirement for sustained and efficient vaccination against leishmaniasis is to formulate the ...
Numerous experimental DNA vaccines have been tested against Leishmania, whose clinical use is mostly...
AbstractObjectiveTo analyze the protective efficacy of recombinant 78 kDa antigen of Leishmania dono...
In this study, we have developed a vaccine with Leishmania donovani promastigote membrane antigens (...
Visceral leishmaniasis is deadly if not treated, and development of a vaccine with long-term immunit...
Liposomes have been widely exploited as antigen delivery systems for a variety of diseases including...
Leishmanial antigens (LAg) were used as a vaccine against Leishmania donovani, the causative agent o...
<div><p>Background</p><p>With the paucity of new drugs and HIV co-infection, vaccination remains an ...
Leishmania proteins have been evaluated as vaccine candidates against leishmaniasis; however, most a...
Background: The observation that recovery from infection with Leishmania confers immunity to reinfec...
Leishmaniasis affects 12 million people, and it is generally agreed that vaccination provides the be...
In the search for a leishmaniasis vaccine, extensive studies of cutaneous leishmaniasis have been ca...
Background: With the paucity of new drugs and HIV co-infection, vaccination remains an unmet researc...
The difficulty in making successful vaccines against leishmaniasis is partly due to lack of an appro...
The difficulty in making successful vaccines against leishmaniasis is partly due to lack of an appro...